CHANDLER POLK: Open Payments
NPI 1285414151 · FLORENCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,044 in 123 payments from 22 companies in 2025. Trend: 2023 $216 · 2024 $2,226 · 2025 $3,044
Food & beverage: $3,044
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $747 |
| Janssen Biotech, Inc. | 9 | $546 |
| GENZYME CORPORATION | 6 | $259 |
| Ardelyx, Inc. | 7 | $211 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $162 |
| Novo Nordisk Inc | 4 | $158 |
| Madrigal Pharmaceuticals | 4 | $151 |
| Ferring Pharmaceuticals Inc. | 5 | $143 |
| Phathom Pharmaceuticals, Inc. | 11 | $102 |
| Gilead Sciences, Inc. | 5 | $98 |
Products named: TREMFYA, DUPIXENT, RINVOQ, IBSRELA, ENTYVIO, SKYRIZI, Wegovy, REZDIFFRA.
Industry payments across SC — which companies pay providers there.
